Carenostics provides underdiagnosis, undertreatment, and health inequities of chronic disease treatment using AI & ML.
Carenostics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Carenostics's investors include Gaingels, GreatPoint Ventures, M13, Kurt Hilzinger.
Carenostics is headquartered in Berwyn, United States.
Carenostics provides underdiagnosis, undertreatment, and health inequities of chronic disease treatment using AI & ML.
Carenostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Carenostics — Funding & Investors." VCBacked, September 13, 2023, https://www.vcbacked.co/company/carenostics. Accessed October 31, 2026.
VCBacked. (2023). Carenostics — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/carenostics
{{cite web |title=Carenostics — Funding & Investors |url=https://www.vcbacked.co/company/carenostics |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated